REFERENCES
- Barton JR, Witlin AG, Sibai BM. Management of mild preeclampsia. Clin Obstet Gynecol. 1999; 42: 455–469
- Sibai B, Dekker G, Kupferminc M. Pre-eclampsia. Lancet. 2005; 365: 785–799
- Lenfant C. National Education Program, Working Group on High Blood Pressure in Pregnancy. Report on high blood pressure in pregnancy. J Clin Hypertens. (Greenwich) 2001; 3: 75–88
- Zamorski MA, Green LA. NHBPEP report on high blood pressure in pregnancy: a summary for family physicians. Am Fam Physician. 2001; 64: 263–270
- Lam C, Lim KH, Kang DH, Karumanchi SA. Uric acid and preeclampsia. Semin Nephrol. 2005; 25: 56–60
- Voto LS, Illia R, Darbon-Grosso HA, Imaz FU, Margulies M. Uric acid levels: a useful index of the severity of preeclampsia and perinatal prognosis. J Perinat Med. 1988; 16: 123–126
- Ramos JGL, Martins-Costa SH, Kessler JB, Costa CA, Barros E. Calciuria and preeclampsia. Braz J Méd Biol Res. 1998; 31: 519–522
- Redman CWG, Beilin LJ, Bonnar J, Wilkinson RH. Plasma-urate measurements in predicting fetal death in hypertensive pregnancy. Lancet. 1976; 1: 1370–1373
- Chan P, Brown M, Simpson JM, Davis G. Proteinuria. in pre-eclampsia: how much matters? BJOG. 2005; 112: 280–285
- Rodriguez-Thompson D, Lieberman ES. Use of a random urinary protein-to-creatinine ratio for the diagnosis of significant proteinuria during pregnancy. Am J Obstet Gynecol. 2001; 185: 808–811
- Neithardt AB, Dooley SL, Borensztajn J. Prediction of 24-hour protein excretion in pregnancy with a single voided urine protein-to-creatinine ratio. Am J Obstet Gynecol. 2002; 186: 883–886
- Ballard JL, Khoury JC, Wedig K, Wang L, Eilers-Walsman BL, Lipp R. New Ballard Score, expanded to include extremely premature infants. J Pediatr. 1991; 119: 417–423
- Shah DM, Reed G. Parameters associated with adverse perinatal outcome in hypertensive pregnancies. J Hum Hypertens. 1996; 10: 511–515
- Lim K-H, Friedman SA, Ecker JL, Kao L, Kilpatrick SJ. The clinical utility of serum uric acid measurements in hypertensive diseases of pregnancy. Am J Obstet Gynecol. 1998; 178: 1067–1071
- Schuster E, Weppelmann B. Plasma urate measurements and fetal outcome in preeclampsia. Gynecol Obstet Invest. 1981; 12: 162–167
- Sagen N, Haram K, Nilsen ST. Serum urate as a predictor of fetal outcome in severe pre-eclampsia. Acta Obstet Gynecol Scand. 1984; 63: 71–75
- Merviel P, Ba R, Beaufils M, Breart G, Salat-Baroux J, Uzan S. Lone hyperuricemia during pregnancy: maternal and fetal outcomes. Eur J Obstet Gynecol Reprod Biol. 1998; 77: 145–150
- Broughton-Pipkin F. Uric acid, endothelial dysfunction and pre-eclampsia. J Hypertens. 2004; 22: 237–239
- Kang D-H, Finch J, Nakagawa T, Karumanchi SA, Kanellis J, Granger J, et al. Uric acid, endothelial dysfunction and pre-eclampsia: searching for a pathogenetic link. J Hypertens. 2004; 22: 229–235
- Kanabrocki EL, Third JL, Ryan MD, Nemchausky BA, Shirazi P, Scheving LE, et al. Circadian relationship of serum uric acid and nitric oxide [Letter]. JAMA. 2000; 283: 2240–2241
- Kanellis J, Kang DH. Uric acid as a mediator of endothelial dysfunction, inflammation, and vascular disease. Semin Nephrol. 2005; 25: 39–42
- May WL, Magann EF, Terrone DA, Rinehart BK, Blake PG, Martin JN, Jr. Early risk assessment of severe preeclampsia: admission battery of symptoms and laboratory tests to predict likelihood of subsequent significant maternal morbidity. Am J Obstet Gynecol. 1999; 180: 1407–1414
- Roberts JM, Bodnar LM, Lain KY, Hubel CA, Markovic N, Ness RB, Powers RW. Uric acid is as important as proteinuria in identifying fetal risk in women with gestational hypertension. Hypertension. 2005; 46: 1263–1269
- Short RA, Tuttle KR. Clinical evidence for the influence of uric acid on hypertension, cardiovascular disease, and kidney disease: a statistical modeling perspective. Semin Nephrol. 2005; 25: 25–31
- Johnson RJ, Kang DH, Feig D, Kivlighn S, Kanellis J, Watanabe S, et al. Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease?. Hypertension. 2003; 41: 1183–1190